Multiple Assemblies exist for SMTL entry 5sk3
Crystal Structure of human phosphodiesterase 10 in complex with [2-cyclopropyl-6-[2-(1-methyl-4-phenylimidazol-2-yl)ethyl]imidazo[1,2-b]pyridazin-3-yl]methanol; X-RAY DIFFRACTION 2.32 Å

	SMTL ID 5sk3.1 Ligands {(4S)-2-cyclopropyl-6-[(1-methyl-4-phenyl-1H-imidazol-2-yl)ethynyl]imidazo[1,2-b]pyridazin-3-yl}methanol; ZINC ION; MAGNESIUM ION Polypeptides cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A Oligo-state monomer
	SMTL ID 5sk3.2 Ligands {(4S)-2-cyclopropyl-6-[(1-methyl-4-phenyl-1H-imidazol-2-yl)ethynyl]imidazo[1,2-b]pyridazin-3-yl}methanol; ZINC ION; MAGNESIUM ION Polypeptides cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A Oligo-state monomer
	SMTL ID 5sk3.3 Ligands {(4S)-2-cyclopropyl-6-[(1-methyl-4-phenyl-1H-imidazol-2-yl)ethynyl]imidazo[1,2-b]pyridazin-3-yl}methanol; ZINC ION; MAGNESIUM ION Polypeptides cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A Oligo-state monomer
	SMTL ID 5sk3.4 Ligands {(4S)-2-cyclopropyl-6-[(1-methyl-4-phenyl-1H-imidazol-2-yl)ethynyl]imidazo[1,2-b]pyridazin-3-yl}methanol; ZINC ION; MAGNESIUM ION Polypeptides cAMP and cAMP-inhibited cGMP 3',5'-cyclic phosphodiesterase 10A Oligo-state monomer